Body composition in pre-pubertal children with cystic fibrosis v1

  • Research type

    Research Study

  • Full title

    To investigate growth, body composition and lung function in pre-pubertal children with cystic fibrosis diagnosed by newborn screening, and era comparison with a historical cohort

  • IRAS ID

    185495

  • Contact name

    Robert Grant

  • Contact email

    robert.grant@sgul.kingston.ac.uk

  • Sponsor organisation

    St George's University of London

  • Duration of Study in the UK

    2 years, 3 months, 30 days

  • Research summary

    Body composition (fat and muscle) may have an effect on health and response to treatment in chronic diseases such as cystic fibrosis (CF). Evidence has established that children with cystic fibrosis (CF) may have altered body composition and that muscle mass is related to lung function. Previous research on body composition in children with CF in the UK has been carried out on unscreened patients. Newborn screening was introduced nationwide in 2007 for CF and gives the opportunity for growth to be optimised as nutritional treatment can start early. Patients diagnosed by newborn screening have been shown to have better growth than those who were unscreened. This study will investigate whether young children with CF who have been diagnosed by newborn screening have normal growth and body composition at 5 to 8 years of age, and the relationship with lung function. This is a single centre study. Patients born July 2007 to July 2012 receiving care at Great Ormond Street Hospital will be eligible for inclusion. Body composition will be measured using a dual-energy X-ray absorptiometry (DXA) scan. This is a quick procedure which measures the amount of fat and muscle in the body. DXA uses a very low level of radiation. Weight and height measurements will also be taken. No other additional procedures will be needed. All other information will be taken from medical notes. This research will provide important evidence as to the benefits of routine assessment of body composition in children with CF and at what age, to help detect changes early.

  • REC name

    London - Brighton & Sussex Research Ethics Committee

  • REC reference

    15/LO/2117

  • Date of REC Opinion

    14 Dec 2015

  • REC opinion

    Favourable Opinion